BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 23891205)

  • 1. Hysteroscopic sterilization success in outpatient vs office setting is not affected by patient or procedural characteristics.
    Anderson TL; Yunker AC; Scheib SA; Callahan TL
    J Minim Invasive Gynecol; 2013; 20(6):858-63. PubMed ID: 23891205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective analysis of office-based hysteroscopic sterilization.
    Levie MD; Chudnoff SG
    J Minim Invasive Gynecol; 2006; 13(2):98-101. PubMed ID: 16527710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hysteroscopic sterilization in patients with a Mirena intrauterine device: transition from extended interval to permanent contraception.
    Tatalovich JM; Anderson TL
    J Minim Invasive Gynecol; 2010; 17(2):228-31. PubMed ID: 20226413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The feasibility, success and patient satisfaction associated with outpatient hysteroscopic sterilisation.
    Sinha D; Kalathy V; Gupta JK; Clark TJ
    BJOG; 2007 Jun; 114(6):676-83. PubMed ID: 17516957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Office hysteroscopic sterilization compared with laparoscopic sterilization: a critical cost analysis.
    Levie MD; Chudnoff SG
    J Minim Invasive Gynecol; 2005; 12(4):318-22. PubMed ID: 16036190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of hysteroscopic sterilization performed in-office versus a hospital operating room.
    Nichols M; Carter JF; Fylstra DL; Childers M;
    J Minim Invasive Gynecol; 2006; 13(5):447-50. PubMed ID: 16962530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hysteroscopic tubal sterilization (essure) in women with an intrauterine device.
    Agostini A; Crochet P; Petrakian M; Estrade JP; Cravello L; Gamerre M
    J Minim Invasive Gynecol; 2008; 15(3):277-9. PubMed ID: 18439497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essure Permanent Birth Control, Effectiveness and Safety: An Italian 11-Year Survey.
    Franchini M; Zizolfi B; Coppola C; Bergamini V; Bonin C; Borsellino G; Busato E; Calabrese S; Calzolari S; Fantin GP; Giarrè G; Litta P; Luerti M; Mangino FP; Marchino GL; Molinari MA; Scatena E; Scrimin F; Telloli P; Di Spiezio Sardo A
    J Minim Invasive Gynecol; 2017; 24(4):640-645. PubMed ID: 28232037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving Rates of Post-Essure Hysterosalpingography in an Urban Population Using Electronic Tracking Reminders.
    Virginia Hu YH; Arora KS
    J Minim Invasive Gynecol; 2017 Feb; 24(2):305-308. PubMed ID: 27867049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-Essure hysterosalpingography compliance in a clinic population.
    Shavell VI; Abdallah ME; Diamond MP; Kmak DC; Berman JM
    J Minim Invasive Gynecol; 2008; 15(4):431-4. PubMed ID: 18588851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Elective Outpatient Hysteroscopic Sterilization in Undocumented Women: A Retrospective Analysis.
    McGuire PJ; Butler J; Gavito C; Sheeder J; Tocce K
    Womens Health Issues; 2017; 27(4):414-419. PubMed ID: 28385588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hysteroscopic Sterilization Device Follow-Up Rate: Hysterosalpingogram Versus Transvaginal Ultrasound.
    Jeirath N; Basinski CM; Hammond MA
    J Minim Invasive Gynecol; 2018; 25(5):836-841. PubMed ID: 29289623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound assessment of the Essure contraceptive devices: is three-dimensional ultrasound really needed?
    Paladini D; Di Spiezio Sardo A; Coppola C; Zizolfi B; Pastore G; Nappi C
    J Minim Invasive Gynecol; 2015 Jan; 22(1):115-21. PubMed ID: 25241073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The feasibility, safety, and effectiveness of hysteroscopic sterilization compared with laparoscopic sterilization.
    Antoun L; Smith P; Gupta JK; Clark TJ
    Am J Obstet Gynecol; 2017 Nov; 217(5):570.e1-570.e6. PubMed ID: 28757140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective cost analysis comparing Essure hysteroscopic sterilization and laparoscopic bilateral tubal coagulation.
    Hopkins MR; Creedon DJ; Wagie AE; Williams AR; Famuyide AO
    J Minim Invasive Gynecol; 2007; 14(1):97-102. PubMed ID: 17218238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in sterilization since the introduction of Essure hysteroscopic sterilization.
    Shavell VI; Abdallah ME; Shade GH; Diamond MP; Berman JM
    J Minim Invasive Gynecol; 2009; 16(1):22-7. PubMed ID: 18996773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Necessity of hysterosalpingography after Essure microinsert placement for contraception.
    Lazarus E; Lourenco AP; Casper S; Allen RH
    AJR Am J Roentgenol; 2012 Jun; 198(6):1460-3. PubMed ID: 22623563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essure: a new device for hysteroscopic tubal sterilization in an outpatient setting.
    Ubeda A; Labastida R; Dexeus S
    Fertil Steril; 2004 Jul; 82(1):196-9. PubMed ID: 15237011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hysteroscopic permanent tubal sterilization using a nitinol-dacron intratubal device without anaesthesia in the outpatient setting: procedure feasibility and effectiveness.
    Litta P; Cosmi E; Sacco G; Saccardi C; Ciavattini A; Ambrosini G
    Hum Reprod; 2005 Dec; 20(12):3419-22. PubMed ID: 16085664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency global endometrial ablation followed by hysteroscopic sterilization.
    Hopkins MR; Creedon DJ; El-Nashar SA; Brown DL; Good AE; Famuyide AO
    J Minim Invasive Gynecol; 2007; 14(4):494-501. PubMed ID: 17630170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.